High VEGFA Expression Is Associated with Improved Progression-Free Survival after Bevacizumab Treatment in Recurrent Glioblastoma

SIMPLE SUMMARY: Glioblastoma (GB) is a deadly tumor that demands for relevant biomarkers, particularly regarding patients’ response to treatment. MMP-2, MMP-9, VEGFA, and YKL40 are important molecules, given their implication in the infiltrative and angiogenic phenotype of GBs. The purpose of this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves, Bárbara, Peixoto, Joana, Macedo, Sofia, Pinheiro, Jorge, Carvalho, Bruno, Soares, Paula, Lima, Jorge, Lima, Raquel T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136662/
https://www.ncbi.nlm.nih.gov/pubmed/37190125
http://dx.doi.org/10.3390/cancers15082196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136662/
https://www.ncbi.nlm.nih.gov/pubmed/37190125
http://dx.doi.org/10.3390/cancers15082196

Ejemplares similares